1. King BA (2013) Notes from the field: electronic cigarette use among middle and high school students—United States, 2011-2012 Morbidity and Mortality Weekly Report (MMWR) Centers for Disease Control and Prevention (CDC), Atlanta, pp. 729–730.

2. Czoli CD, Hammond D, White CM (2014) Electronic cigarettes in Canada: prevalence of use and perceptions among youth and young adults. Can J Public Health Revue Canadienne de Sante Publique 105:e97–e102

3. Kinnunen JM, Ollila H, El-Amin SE, Pere LA, Lindfors PL, Rimpela AH (2014) Awareness and determinants of electronic cigarette use among Finnish adolescents in 2013: a population-based study. Tob Control. doi:10.1136/tobaccocontrol-2013-051512

4. Lee S, Grana RA, Glantz SA (2014) Electronic cigarette use among Korean adolescents: a cross-sectional study of market penetration, dual use, and relationship to quit attempts and former smoking. J Adolesc Health: Off Publ Soc Adolesc Med 54:684–690

5. Bostean G, Trinidad DR, McCarthy WJ (2015) E-cigarette use among never-smoking California students. American journal of public health: e1-e3. DOI 10.2105/AJPH.2015.302899

6. Sutfin EL, McCoy TP, Morrell HE, Hoeppner BB, Wolfson M (2013) Electronic cigarette use by college students. Drug Alcohol Depend 131:214–221

7. Regan AK, Promoff G, Dube SR, Arrazola R (2013) Electronic nicotine delivery systems: adult use and awareness of the 'e-cigarette' in the USA. Tob Control 22:19–23

8. Brown J, West R, Beard E, Michie S, Shahab L, McNeill A (2014) Prevalence and characteristics of e-cigarette users in Great Britain: findings from a general population survey of smokers. Addict Behav 39:1120–1125

9. Dawkins L, Turner J, Roberts A, Soar K (2013) 'Vaping' profiles and preferences: an online survey of electronic cigarette users. Addiction 108:1115–1125

10. Bauguess AJ (2014) How to make your own e-liquid (e-juice). ecigvape.com.

11. Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, Wallace Hayes A, Tsatsakis AM, Koutedakis Y (2013) Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 25:91–101

12. Liu GY (2009) Molecular pathogenesis of Staphylococcus aureus infection. Pediatr Res 65:71R–77R

13. McEachern EK, Hwang JH, Sladewski KM, Nicatia S, Dewitz C, Mathew DP, Nizet V, Alexander LE (2015) Analysis of the effects of cigarette smoke on staphylococcal virulence phenotypes. Infect Immun 83:2443–2452

14. Crotty Alexander LE, Shin S, Hwang JH (2015) Inflammatory diseases of the lung induced by conventional cigarette smoke: a review. Chest. doi:10.1378/chest.15-0409

15. Foster KA, Oster CG, Mayer MM, Avery ML, Audus KL (1998) Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res 243:359–366

16. Grando SA (2008) Basic and clinical aspects of non-neuronal acetylcholine: biological and clinical significance of non-canonical ligands of epithelial nicotinic acetylcholine receptors. J Pharmacol Sci 106:174–179

17. Thunnissen FB (2009) Acetylcholine receptor pathway and lung cancer. J Thorac Oncol: Off Publ Int Assoc Study Lung Cancer 4:943–946

18. Bermudez Y, Benavente CA, Meyer RG, Coyle WR, Jacobson MK, Jacobson EL (2011) Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation. PLoS ONE 6, e20487. doi:10.1371/journal.pone.0020487

19. Reynolds PR, Allison CH, Willnauer CP (2010) TTF-1 regulates alpha5 nicotinic acetylcholine receptor (nAChR) subunits in proximal and distal lung epithelium. Respir Res 11:175

20. Ma X, Jia Y, Zu S, Li R, Zhao Y, Xiao D, Dang N, Wang Y (2014) alpha5 Nicotinic acetylcholine receptor mediates nicotine-induced HIF-1alpha and VEGF expression in non-small cell lung cancer. Toxicol Appl Pharmacol 278:172–179

21. Comer DM, Elborn JS, Ennis M (2014) Inflammatory and cytotoxic effects of acrolein, nicotine, acetylaldehyde and cigarette smoke extract on human nasal epithelial cells. BMC Pulm Med 14:32

22. Streck E, Jorres RA, Huber RM, Bergner A (2010) Effects of cigarette smoke extract and nicotine on bronchial tone and acetylcholine-induced airway contraction in mouse lung slices. J Investig Allergol Clin Immunol 20:324–330

23. Askarian F, Sangvik M, Hanssen AM, Snipen L, Sollid JU, Johannessen M (2014) Staphylococcus aureus nasal isolates from healthy individuals cause highly variable host cell responses in vitro: the Tromso Staph and Skin Study. Pathog Dis 70:158–166

24. Pegtel DM, Subramanian A, Sheen TS, Tsai CH, Golub TR, Thorley-Lawson DA (2005) Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol 79:15430–15442

25. Condliffe AM, Kitchen E, Chilvers ER (1998) Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci 94:461–471

26. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM (2002) Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 22:1668–1673

27. Rohde LE, Hennekens CH, Ridker PM (1999) Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol 84:1018–1022

28. Magnusson KE (1982) Hydrophobic interaction—a mechanism of bacterial binding. Scand J Infect Dis Suppl 33:32–36

29. Dahlback B, Hermansson M, Kjelleberg S, Norkrans B (1981) The hydrophobicity of bacteria—an important factor in their initial adhesion at the air-water interface. Arch Microbiol 128:267–270

30. Yang ES, Tan J, Eells S, Rieg G, Tagudar G, Miller LG (2010) Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis 16:425–431

31. Wang G (2008) Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J Biol Chem 283:32637–32643

32. Neville F, Cahuzac M, Konovalov O, Ishitsuka Y, Lee KY, Kuzmenko I, Kale GM, Gidalevitz D (2006) Lipid headgroup discrimination by antimicrobial peptide LL-37: insight into mechanism of action. Biophys J 90:1275–1287

33. Neville F, Gidalevitz D, Kale G, Nelson A (2007) Electrochemical screening of anti-microbial peptide LL-37 interaction with phospholipids. Bioelectrochemistry 70:205–213

34. Park EJ, Lee GH, Yoon C, Jeong U, Kim Y, Cho MH, Kim DW (2015) Biodistribution and toxicity of spherical aluminum oxide nanoparticles. J Appl Toxicol: JAT. doi:10.1002/jat.3233

35. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282:490–493

36. Herzog E, Casey A, Lyng FM, Chambers G, Byrne HJ, Davoren M (2007) A new approach to the toxicity testing of carbon-based nanomaterials—the clonogenic assay. Toxicol Lett 174:49–60

37. Farsalinos KE, Romagna G, Allifranchini E, Ripamonti E, Bocchietto E, Todeschi S, Tsiapras D, Kyrzopoulos S, Voudris V (2013) Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health 10(10):5146–5162

38. Schweitzer KS, Chen SX, Law S, Van Demark M, Poirier C, Justice MJ, Hubbard WC, Kim ES, Lai X, Wang M et al (2015) Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am J Physiol Lung Cell Mol Physiol 309(2):L175–L187

39. Savill J, Dransfield I, Gregory C, Haslett C (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2:965–975

40. Kaczmarek A, Vandenabeele P, Krysko DV (2013) Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38:209–223

41. El Mezayen R, El Gazzar M, Seeds MC, McCall CE, Dreskin SC, Nicolls MR (2007) Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett 111:36–44

42. Radsak MP, Taube C, Haselmayer P, Tenzer S, Salih HR, Wiewrodt R, Buhl R, Schild H (2007) Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease. Clin Dev Immunol 2007:52040

43. Papanikolaou IC, Boki KA, Giamarellos-Bourboulis EJ, Kotsaki A, Kagouridis K, Karagiannidis N, Polychronopoulos VS (2015) Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases. Immunol Lett 163:179–186

44. Molad Y, Ofer-Shiber S, Pokroy-Shapira E, Oren S, Shay-Aharoni H, Babai I (2015) Soluble triggering receptor expressed on myeloid cells-1 is a biomarker of anti-CCP-positive, early rheumatoid arthritis. Eur J Clin Investig 45:557–564

45. Sussan TE, Gajghate S, Thimmulappa RK, Ma J, Kim JH, Sudini K, Consolini N, Cormier SA, Lomnicki S, Hasan F et al (2015) Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. PLoS ONE 10(2), e0116861. doi:10.1371/journal.pone.0116861

46. Wu Q, Jiang D, Minor M, Chu HW (2014) Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells. PLoS ONE 9(9), e108342. doi:10.1371/journal.pone.0108342

47. Cheng AG, McAdow M, Kim HK, Bae T, Missiakas DM, Schneewind O (2010) Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog 6, e1001036. doi:10.1371/journal.ppat.1001036

48. Hamilton SM, Bryant AE, Carroll KC, Lockary V, Ma Y, McIndoo E, Miller LG, Perdreau-Remington F, Pullman J, Risi GF et al (2007) In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections. Clin Infect Dis: Off Publ Infect Dis Soc Am 45:1550–1558

49. Montgomery CP, Boyle-Vavra S, Adem PV, Lee JC, Husain AN, Clasen J, Daum RS (2008) Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J Infect Dis 198:561–570

50. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Vandenesch F, Piemont Y, Brousse N, Floret D et al (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753–759